Prognostic value of microRNA-495-3p, adiponectin, and cardiometabolic index in type 2 diabetic nephropathy

Table 4 Univariate analysis affecting the prognosis of patients in the study group, mean ± SD

Group	Good outcome (n = 61)	Poor outcome (n = 37)	t value	P value
Age (years)	45.98 ± 5.78	45.74 ± 6.23	0.193	0.847
Gender (male/female)	26/35	16/21	0.004	0.952
Duration (years)	5.01 ± 1.03	5.27 ± 1.23	-1.125	0.263
BMI (kg/m2)	25.31 ± 1.39	25.57 ± 1.46	-1.220	0.226
Fasting insulin (mIU/L)	14.26 ± 1.56	14.55 ± 1.68	-0.867	0.388
FBG (mmol/L)	8.99 ± 1.56	8.91 ± 1.61	0.243	0.808
Glycosylated hemoglobin (%)	9.95 ± 1.22	9.89 ± 0.81	0.265	0.791
Low density lipoprotein (mmol/L)	1.97 ± 0.61	3.77 ± 0.52	-14.948	< 0.001
High density lipoprotein (mmol/L)	1.36 ± 0.45	0.89 ± 0.21	5.963	< 0.001
Triglyceride (mmol/L)	1.39 ± 0.34	3.23 ± 0.56	-20.266	< 0.001
Total cholesterol (mmol/L)	4.46 ± 1.78	8.78 ± 1.26	-12.918	< 0.001
Heart rate (beats/minute)	70.28 ± 8.13	71.55 ± 8.46	-0.738	0.462
24-hour systolic blood pressure (mmHg)	122.46 ± 21.05	152.12 ± 21.02	-8.061	0.000
24-hour diastolic blood pressure (mmHg)	78.16 ± 3.79	78.68 ± 4.11	-0.638	0.525
Alanine aminotransferase (U/L)	30.55 ± 9.05	85.11 ± 8.46	-29.642	< 0.001
Aspartate aminotransferase (U/L)	32.11 ± 8.12	76.15 ± 7.48	149.069	< 0.001
Urea nitrogen (mmol/L)	8.44 ± 1.78	16.66 ± 1.22	-32.857	< 0.001
Serum creatinine (μmol/L)	87.26 ± 12.02	126.26 ± 9.64	-16.730	< 0.001

FBG: Fasting blood glucose; BMI: Body mass index.